Calibration of an intrahost malaria model and parameter ensemble evaluation of a pre-erythrocytic vaccine

Malaria Journal

Volumn 14, Issue 1, 2015, Pages

  McCarthy, Kevin A ^a   Wenger, Edward A ^a   Huynh, Grace H ^a   Eckhoff, Philip A ^a  

^a INSTITUTE FOR DISEASE MODELING   (United States)

Author keywords

Calibration; Ensemble; Model; Pre erythrocytic; Vaccine

Indexed keywords

MALARIA VACCINE; PRE ERYTHROCYTIC VACCINE; UNCLASSIFIED DRUG;

AFRICA; ANTIGENIC VARIATION; ARTICLE; CALIBRATION; DISEASE SEVERITY; HUMAN; IMMUNE SYSTEM; IMMUNIZATION; INCIDENCE; MALARIA; MORBIDITY; PREVALENCE; SPECIES DIFFERENCE; ADOLESCENT; ADULT; CHILD; DISEASE TRANSMISSION; FEMALE; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PREVENTION AND CONTROL; PROCEDURES; THEORETICAL MODEL; TRANSMISSION; VACCINATION; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICA; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA; MALARIA VACCINES; MALE; MIDDLE AGED; MODELS, THEORETICAL; VACCINATION; YOUNG ADULT;

EID: 84928678879     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-14-6     Document Type: Article

References (45)

1. WHO. World Malaria Report: 2013. Geneva: World Health Organization; 2013.
2. Akachi Y, Atun R. Effect of investment in malaria control on child mortality in sub-Saharan Africa in 2002-2008. PLoS ONE. 2011;6:e21309.
3. Lim SS, Fullman N, Stokes A, Ravishankar N, Masiye F, Murray CJL, et al. Net benefits: a multicountry analysis of observational data examining associations between insecticide-treated mosquito nets and health outcomes. PLoS Med. 2011;8:e1001091.
4. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005;434:214-7.
5. Eckhoff PA. A malaria transmission-directed model of mosquito life cycle and ecology. Malar J. 2011;10:303.
6. Eckhoff PA. Malaria parasite diversity and transmission intensity affect development of parasitological immunity in a mathematical model. Malar J. 2012;11:419.
7. Eckhoff P. Mathematical models of within-host and transmission dynamics to determine effects of malaria interventions in a variety of transmission settings. Am J Trop Med Hyg. 2013;88:817-27.
8. Eckhoff P. P. falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model. PLoS ONE. 2012;7:e44950.
9. Wenger EA, Eckhoff PA. A mathematical model of the impact of present and future malaria vaccines. Malar J. 2013;12:126.
10. Girard MP, Reed ZH, Friede M, Kieny MP. A review of human vaccine research and development: malaria. Vaccine. 2007;25:1567-80.
11. White NJ. Antimalarial drug resistance. J Clin Invest. 2004;113:1084-92.
12. Hemingway J, Ranson H. Insecticide resistance in insect vectors of human disease. Annu Rev Entomol. 2000;45:371-91.
13. RTS, S Clinical Trials Partnership. Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 2014;11:e1001685.
14. Olotu AI. Long Term Efficacy of a Pre-Erythrocytic Malaria Vaccine and Correlates of Protection in Children Residing in a Malaria Endemic Country, Ph. D. Thesis. University of Oxford; 2013.
15. White MT, Bejon P, Olotu A, Griffin JT, Bojang K, Lusingu J, et al. A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS, S malaria vaccine. BMC Med. 2014;12:117.
16. Regules JA, Cummings JF, Ockenhouse CF. The RTS, S vaccine candidate for malaria. Expert Rev Vaccines. 2011;10:589-99.
17. Konaté AT, Yaro JB, Ouédraogo AZ, Diarra A, Gansané A, Soulama I, et al. Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial. PLoS ONE. 2011;6:e23391.
18. Aponte JJ, Menendez C, Schellenberg D, Kahigwa E, Mshinda H, Vountasou P, et al. Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation. PLoS Med. 2007;4:e242.
19. Maire N, Tediosi F, Ross A, Smith T. Predictions of the epidemiologic impact of introducing a pre-erythrocytic vaccine into the expanded program on immunization in sub-Saharan Africa. Am J Trop Med Hyg. 2006;75(2 suppl):111-8.
20. Smith T, Killeen GF, Maire N, Ross A, Molineaux L, Tediosi F, et al. Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: overview. Am J Trop Med Hyg. 2006;75(2 suppl):1-10.
21. Horrocks P, Kyes SA, Bull PC, Deitsch KW. Molecular Aspects of Antigenic Variation in Plasmodium falciparum. In: Sherman IW, editor. Mol Approaches Malar. 2005. p. 399-415.
22. Recker M, Buckee CO, Serazin A, Kyes S, Pinches R, Christodoulou Z, et al. Antigenic variation in Plasmodium falciparum malaria involves a highly structured switching pattern. PLoS Pathog. 2011;7:e1001306.
23. Holder AA, Guevara Patiño JA, Uthaipibull C, Syed SE, Ling IT, Scott-Finnigan T, et al. Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Parassitologia. 1999;41:409-14.
24. Molineaux L, Gramiccia G. The Garki Project: Research on the Epidemiology and Control of Malaria in the Sudan Savanna of West Africa. Geneva: World Health Organization; 1980. p. 311.
25. Smith T, Charlwood JD, Kihonda J, Mwankusye S, Billingsley P, Meuwissen J, et al. Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission. Acta Trop. 1993;54:55-72.
26. Rogier C, Tall A, Diagne N, Fontenille D, Spiegel A, Trape JF. Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal. Parassitologia. 1999;41:255-9.
27. Trape JF, Rogier C, Konate L, Diagne N, Bouganali H, Canque B, et al. The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg. 1994;51:123-37.
28. Rogier C, Trape J-F. Etude de l'acquisition de la prémunition en zones d'holo-et de méso-endémie palustre et Dielmo et a Ndiop (Sénégal): Résultats préliminaires, 1990-1994. Méd Trop (Marseille). 1995;55:71-6.
29. Smith T, Schellenberg JA, Hayes R. Attributable fraction estimates and case definitions for malaria in endemic areas. Stat Med. 1994;13:2345-58.
30. Snow RW, Craig M, Deichmann U, Marsh K. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ. 1999;77:624-40.
31. Patil AP, Okiro EA, Gething PW, Guerra CA, Sharma SK, Snow RW, et al. Defining the relationship between Plasmodium falciparum parasite rate and clinical disease: statistical models for disease burden estimation. Malar J. 2009;8:186.
32. Carnevale P, Frezil J, Bosseno M, Lepont F, Lancien J. Study of agressivity of Anopheles gambiae in relation to age and sex. Bull World Health Organ. 1978;56:147-54.
33. Port GR, Boreham PFL, Bryan JH. The relationship of host size to feeding by mosquitoes of the Anopheles gambiae Giles complex (Diptera: Culicidae). Bull Entomol Res. 1980;70:133-44.
34. Smith T, Maire N, Dietz K, Killeen GF, Vounatsou P, Molineaux L, et al. Relationship between the entomologic inoculation rate and the force of infection for Plasmodium falciparum malaria. Am J Trop Med Hyg. 2006;75(2 Suppl):11-8.
35. Raftery AE, Bao L. Estimating and projecting trends in HIV/AIDS generalized epidemics using incremental mixture importance sampling. Biometrics. 2010;66:1162-73.
36. Steele RJ, Raftery AE, Emond MJ. Computing normalizing constants for finite mixture models via incremental mixture importance sampling (IMIS. J Comput Graph Stat. 2006;15:712-34.
37. Snow RW, Omumbo JA, Lowe B, Molyneux CS, Obiero JO, Palmer A, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet. 1997;349:1650-4.
38. Okiro EA, Al-Taiar A, Reyburn H, Idro R, Berkley JA, Snow RW. Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity. Malar J. 2009;8:4.
39. Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med. 1999;5:340-3.
40. Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IR, Johnston GL, et al. A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J. 2011;10:378.
41. Smith DL, Dushoff J, Snow RW, Hay SI. The entomological inoculation rate and Plasmodium falciparum infection in African children. Nature. 2005;438:492-5.
42. Griffin JT, Ferguson NM, Ghani AC. Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa. Nat Commun. 2014;5:3136.
43. Woolhouse MEJ, Dye C, Etard J-F, Smith T, Charlwood JD, Garnett GP, et al. Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A. 1997;94:338-42.
44. Walther M, Woodruff J, Edele F, Jeffries D, Tongren JE, King E, et al. Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes. J Immunol. 2006;177:5736-45.
45. White MT, Griffin JT, Drakeley CJ, Ghani AC. Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials. Malar J. 2010;9:82.